Diagnosis of a rare disease, lack of therapies, and small patient populations all lead to significant challenges in rare disease management and support of these patients. Through patient support programs, pharmaceutical companies provide targeted assistance to help overcome the barriers that get in the way of treatment initiation and adherence.
Email is a critical channel for reaching rare disease patients. However, email campaigns should be targeted at the right patients with the right messages at the right time, backed up by KPIs, and integrated with other promotional channels. Further, enterprise-grade digital marketing platforms that allow automation and management of email campaigns, including sending behavior-triggered emails and analysis of results, can help optimize campaigns, enhance the overall scale, and ultimately improve patient outcomes.
Axtria brought its deep expertise in managing campaigns across multiple channels and enabled the setting up of email-marketing campaigns for its client's brands in an enterprise-grade digital marketing platform. The impact generated for the client included:
- Improved segmentation, targeting, and messaging leading to improved email delivery
- Improved email content leading to higher patient engagement
The client benefited from:
Accelerated patient journey
Better customer experience
Improved brand adherence
Read this illustration to know how Axtria engaged with a global biopharmaceutical company to move its patient experience to the next level, ultimately accelerating the patient journey to brand advocacy via simple changes to patient and caregiver email campaigns for its brands.
Download the free case study here.
Contact us at insights@axtria.com with any questions.
Recommended insights
Report
Blog
Blog